Clinical Trial Update: Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial comparing hydrocortisone alone versus hydrocortisone plus fludrocortisone for adrenal insufficiency in severe sepsis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency
• Sepsis

Drugs mentioned

• Fludrocortisone (Fludrocortisone)
• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: CAMC Health System | Conditions: Sepsis, Adrenal Insufficiency | Phase 4 | Status: WITHDRAWN